The WACC of Modern Healthcare Technology Holdings Ltd (919.HK) is 8.7%.
Range | Selected | |
Cost of equity | 5.3% - 8.5% | 6.9% |
Tax rate | 7.9% - 10.0% | 8.95% |
Cost of debt | 4.1% - 19.9% | 12% |
WACC | 4.6% - 12.8% | 8.7% |
Category | Low | High |
Long-term bond rate | 2.9% | 3.4% |
Equity market risk premium | 6.0% | 7.0% |
Adjusted beta | 0.33 | 0.59 |
Additional risk adjustments | 0.5% | 1.0% |
Cost of equity | 5.3% | 8.5% |
Tax rate | 7.9% | 10.0% |
Debt/Equity ratio | 0.84 | 0.84 |
Cost of debt | 4.1% | 19.9% |
After-tax WACC | 4.6% | 12.8% |
Selected WACC | 8.7% | |
Debt/Equity | Unlevered | |||
Peers | Company Name | ratio | Beta | beta |
919.HK | Modern Healthcare Technology Holdings Ltd | 0.84 | -0.34 | -0.19 |
1827.HK | Miricor Enterprises Holdings Ltd | 0.19 | -0.08 | -0.06 |
1830.HK | Perfect Shape Medical Ltd | 0.12 | 0.7 | 0.63 |
2700.HK | Green International Holdings Ltd | 0.1 | -0.02 | -0.01 |
79.HK | Century Legend (Holdings) Ltd | 3.27 | 0.02 | 0 |
8181.HK | Shi Shi Services Ltd | 0.09 | -0.23 | -0.22 |
8296.HK | Sino-Life Group Ltd | 0.81 | 0.57 | 0.33 |
8483.HK | Max Sight Group Holdings Ltd | 0.11 | 0.34 | 0.31 |
8603.HK | Fameglow Holdings Ltd | 0.09 | 0.37 | 0.35 |
922.HK | Anxian Yuan China Holdings Ltd | 0.05 | 0.16 | 0.16 |
Low | High | |
Unlevered beta | 0 | 0.22 |
Relevered beta | 0 | 0.39 |
Adjusted relevered beta | 0.33 | 0.59 |
The Cost of Equity reflects the return a company needs to deliver to shareholders to justify the risk of investing in its shares. It’s computed using the Capital Asset Pricing Model (CAPM), which blends the risk-free rate, the stock’s beta, and the market risk premium.
This method evaluates the stock’s risk compared to a safe investment and the market’s overall volatility.
Here’s how we figure out the cost of equity for 919.HK:
cost_of_equity (6.90%) = risk_free_rate (3.15%) + equity_risk_premium (6.50%) * adjusted_beta (0.33) + risk_adjustments (0.75%)
We include the risk adjustments, which range from 0% to 1%, to keep our WACC conservatives, especially for companies traded in developing markets.